Present status of therapy for anaerobic infections

Clinical Infectious Diseases

Volumn 23, Issue SUPPL. 1, 1996, Pages

  Finegold, Sydney M ^a,b   Wexler, Hannah M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINAFLOXACIN; CLINDAMYCIN; GENTAMICIN; IMIPENEM; LATAMOXEF; METRONIDAZOLE; MINOCYCLINE; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; SULTAMICILLIN; TETRACYCLINE; TICARCILLIN; TIMENTIN; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ANAEROBIC BACTERIUM; ANAEROBIC INFECTION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE GENITAL TRACT INFECTION; FOOT ULCER; HUMAN; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; SKIN ABSCESS; ANTIBIOTIC RESISTANCE; CLASSIFICATION; DEBRIDEMENT; DRUG EFFECT; FEMALE; MULTIMODALITY CANCER THERAPY; REVIEW; WOUND DRAINAGE;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; COMBINED MODALITY THERAPY; DEBRIDEMENT; DRAINAGE; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS;

EID: 0029834843     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.supplement_1.s9     Document Type: Article

References (9)

1. Civen R, Jousimies-Somer H, Marina M, Borenstein L, Shah H, Finegold SM. A retrospective review of cases of anaerobic empyema and update of bacteriology. Clin Infect Dis 1995;20 (suppl 2):S224-9.
2. Bennion RS, Thompson JE, Baron EJ, Finegold SM. Gangrenous and perforated appendicitis with peritonitis - treatment and bacteriology. Clin Ther 1990; 12(suppl C):13-24.
3. Duerden BI. Anaerobes in genitourinary infections. In: Duerden BI, Drasar BS, eds. Anaerobes in human disease. New York: Wiley-Liss, 1991.
4. Sapico FL, Canawati HN, Witte JL, et al. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol 1980; 12:413-20.
5. Summanen PH, Talan DA, Strong C, et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis 1995; 20(suppl 2):S279-82.
6. Stevens DL, Maier KA, Laine BM, Mitten JE. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis 1987; 155:220-8.
7. Wexler HM, Reeves D, Summanen PH, et al. Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic Campylobacter gracilis - like clinical isolates. Int J Syst Bacteriol 1996;46:252-8.
8. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard; 3rd ed. NCCLS document M11-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
9. Finegold SM, Wexler HM. Anaerobic infections. In: Schlossberg D, ed. Current therapy of infectious disease. St. Louis: Mosby, 1996:369-75.